
Quotient Limited QTNT
Quarterly report 2022-Q4
added 02-09-2023
Quotient Limited Shares 2011-2026 | QTNT
Annual Shares Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 91.6 M | 71.6 M | 54.9 M | 40.8 M | 28.1 M | 19.6 M | 14.8 M | 18.4 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 91.6 M | 14.8 M | 42.5 M |
Quarterly Shares Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.25 M | 3.71 M | 3.44 M | 2.57 M | 2.55 M | 2.54 M | 2.54 M | 101 M | 101 M | 83.9 M | 83.9 M | 80.5 M | 73.8 M | 73.8 M | 66.3 M | 66.1 M | 56.6 M | 56.6 M | 52.1 M | 45.6 M | 43.4 M | 37.7 M | 36.8 M | 29.6 M | 29.5 M | 27.7 M | 26.8 M | 25.4 M | 20.4 M | 18.3 M | 17.2 M | 17 M | 15.1 M | 14.4 M | 12.8 M | 342 K | 829 K | 144 K | 237 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 101 M | 144 K | 34.3 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
304 M | $ 117.74 | -1.68 % | $ 35.8 B | ||
|
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 19.95 | -2.97 % | $ 211 M | ||
|
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
53.3 M | $ 22.11 | 25.81 % | $ 1.18 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M | ||
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M | ||
|
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
1.33 M | $ 1.42 | - | $ 1.89 M | ||
|
Castle Biosciences
CSTL
|
27.8 M | $ 24.49 | -0.53 % | $ 680 M | ||
|
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
49.6 M | $ 179.73 | -0.51 % | $ 8.91 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
713 M | $ 194.65 | -1.74 % | $ 139 B | ||
|
Interpace Biosciences
IDXG
|
4.42 M | $ 1.93 | -12.09 % | $ 8.54 M | ||
|
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
159 M | $ 130.0 | -1.71 % | $ 20.7 B | ||
|
Medpace Holdings
MEDP
|
28.8 M | $ 521.19 | 0.51 % | $ 15 B | ||
|
Fulgent Genetics
FLGT
|
30.2 M | $ 16.04 | -0.8 % | $ 485 M | ||
|
NeoGenomics
NEO
|
128 M | $ 8.39 | -3.34 % | $ 1.07 B | ||
|
Neogen Corporation
NEOG
|
217 M | $ 9.18 | -2.55 % | $ 1.99 B | ||
|
Guardant Health
GH
|
125 M | $ 85.27 | 0.48 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
32.5 K | $ 2.84 | -3.07 % | $ 92.2 K | ||
|
Biomerica
BMRA
|
2.3 M | $ 2.19 | 4.03 % | $ 5.03 M | ||
|
Koninklijke Philips N.V.
PHG
|
904 M | $ 29.07 | - | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
82.5 M | $ 115.89 | -0.52 % | $ 9.56 B | ||
|
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 267.91 | 0.38 % | $ 22.3 B | ||
|
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | ||
|
Celcuity
CELC
|
46.8 M | $ 122.94 | -0.43 % | $ 5.75 B | ||
|
Senseonics Holdings
SENS
|
41.7 M | $ 6.78 | -1.74 % | $ 283 M | ||
|
Myriad Genetics
MYGN
|
92.6 M | $ 5.16 | -0.67 % | $ 478 M | ||
|
Lantheus Holdings
LNTH
|
67.5 M | $ 83.51 | -0.51 % | $ 5.64 B | ||
|
Soleno Therapeutics
SLNO
|
50.8 M | $ 52.62 | 0.1 % | $ 2.67 B | ||
|
Neuronetics
STIM
|
66 M | $ 1.36 | -2.52 % | $ 89.7 M | ||
|
Quest Diagnostics Incorporated
DGX
|
111 M | $ 193.55 | 1.16 % | $ 21.5 B | ||
|
ENDRA Life Sciences
NDRA
|
787 K | $ 5.2 | 1.17 % | $ 4.09 M | ||
|
Thermo Fisher Scientific
TMO
|
377 M | $ 522.74 | -1.65 % | $ 197 B | ||
|
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M | ||
|
National Research Corporation
NRC
|
22.4 M | $ 17.81 | -0.17 % | $ 399 M |